Avania Group B.V.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Avania Group B.V. - overview
Established
1988
Location
-, -, Netherlands
Primary Industry
Outsourcing
About
Avania Group B. V. is a global contract research organization (CRO) that specializes in advancing medical technologies through comprehensive services from development to commercialization. Founded in 1988 in the Netherlands, Avania Group B.
V. provides integrated services in medical technology. The company has undergone strategic pivots but maintains a focus on supporting clients in the regulatory landscape. CEO Sapna H leads the company, which has been involved in two deals, with the most recent occurring on June 20, 2022.
Avania offers end-to-end services including strategic consulting, product development, data analytics, safety compliance, clinical operations, and market access solutions. Their expertise aids a diverse clientele, including medical device manufacturers and biotech firms in navigating regulatory submissions and conducting clinical studies across North America, Europe, and parts of Asia. In 2021, Avania reported an EBITDA of USD 7,554,265. 40.
Their revenue model is based on project-based contracts with fixed fees for services such as clinical trial management and regulatory consulting, ensuring tailored solutions for healthcare clients throughout the product development lifecycle. The acquisition in June 2022 by Astorg aims to accelerate Avania Group B. V. 's growth through organic initiatives and further acquisitions.
The company plans to expand into new markets in Asia and Europe by the end of 2023, leveraging the recent investment to enhance service capacities and support upcoming product launches designed to address specific regulatory challenges.
Current Investors
Kester Capital
Primary Industry
Outsourcing
Sub Industries
Consulting Services, Outsourcing, Medical Devices & Equipment, Analytics & Performance Software
Website
www.avaniaclinical.com
Verticals
HealthTech
Total Amount Raised
Subscriber access only
Avania Group B.V. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Anagram Esic, SL | - | ||||||||
| Add-on | Completed | Ironstone Product Development | - | ||||||||
| Add-on | Completed | Hull Associates, LLC | - | ||||||||
| Add-on | Completed | MAXIS, LLC | - | ||||||||
| Secondary Buyout | Completed | Avania Group B.V. | - |
Displaying 1 - 5 of 8
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.